European Medicines Agency completes its review of Avastin used in breast cancer

View source ↗

Summary

EMA completes its review of Avastin's use in breast cancer, likely concluding on its safety/efficacy for this indication with regulatory actions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)